Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

May 31, 2015 - 9:01 a.m.
Zydelig® in Combination With Ofatumumab Improves Progression-Free Survival in Previously-Treated Patients With Chronic Lymphocytic LeukemiaPrinter Friendly Version 
May 28, 2015 - 8:31 a.m.
European Medicines Agency Validates Gilead’s Marketing Application for Fixed-Dose Combination of Emtricitabine and Tenofovir Alafenamide for HIV TreatmentPrinter Friendly Version 

Upcoming Events

Friday, May 29, 2015 through Tuesday, June 2, 2015
American Society of Clinical Oncology (ASCO)
LocationChicago, IL
Tuesday, June 9, 2015 9:30 a.m. CT
William Blair 34th Annual Growth Stock Conference
LocationChicago, IL
Tuesday, June 9, 2015 10:00 a.m. PT
Goldman Sachs 35th Annual Global Healthcare Conference
LocationRancho Palos Verdes, CA
Thursday, June 11, 2015 through Sunday, June 14, 2015
20th Congress of the European Hematology Association (EHA)
LocationVienna, Austria

Most Viewed Links

Updated 05/20/15
1.Earnings
2.SEC Filings
3.Stock Information
4.Annual Reports
5.Bank of America Merrill Lynch 2015 Health Care Conference
* Data collected 05/12/15 - 05/19/15

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.